Enhanced Selective Degradation of Pharmaceutical and Personal Care Products by β-Cyclodextrin-Decorated ZIF-67 Nanocomposites in Reclaimed Water
ACS Applied Materials & Interfaces · 2024
DOI: 10.1021/acsami.4c05315 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Xi Quan und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Urban Water Resource and Environment (SKLUWRE), Joint Research Center of Biomass Energy Development and Utilization, Harbin I…. Hauptthemen laut MEDLINE: beta-Cyclodextrins, Water Pollutants, Chemical, Carbamazepine, Nanocomposites. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Natural Science Foundation of Chongqing Municipality, Natural Science Foundation of Heilongjiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
A peroxymonosulfate oxidation system was developed via modification of β-cyclodextrin (β-CD) on the surface of Fe2+-doped ZIF-67 (CD/Fe@ZIF-67) as an activator. The 99.7% carbamazepine, 91.3% bisphenol A (BPA), and 95.4% diclofenac (DCF) degradation efficiency were achieved within 10 min, 60, and 1 min, respectively. The hydrophobicity of these three pollutants is positively correlated with their adsorption kinetic constants by CD/Fe@ZIF-67 due to the introduction of β-CD. Scavenger experiments and electron spin resonance spectra confirmed that carbamazepine was preferentially oxidized by SO4•- [λ(SO4•-)(70.5%) > λ(•OH)(28.2%) > λ(O2•-)(1.3%)], where SO4•- and O2•- played dominant roles in the degradation of BPA [λ(SO4•-)(71.7%) > λ(O2•-)(22.8%) > λ(•OH)(5.5%)], and O2•- was responsible for DCF removal [λ(O2•-) = 93.2%]. Additionally, the particulate catalyst was immobilized in the shell side of a ceramic membrane in a membrane reactor for catalyst recovery. This reactor achieved nearly 100% removal efficiency under optimal conditions: 0.036 wt % catalyst loading, 0.5 mM peroxymonosulfate concentration, 1 L inflow, 10 mg/L initial carbamazepine concentration, and 0.012 L/min hydraulic retention time. In summary, this study elucidates the active role of β-CD in a polymetallic/peroxymonosulfate system and provides valuable insights into the development of effective oxidation methods for pharmaceutical and personal care products in wastewater.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Urban Water Resource and Environment (SKLUWRE), Joint Research Center of Biomass Energy Development and Utilization, Harbin Institute of Technology, Harbin 150090, China.
- Chongqing Research Institute of HIT, Chongqing 401151, China.
ORCID-Profile: Jun Zhang
Förderung
- Natural Science Foundation of Chongqing Municipality
- Natural Science Foundation of Heilongjiang Province
- National Natural Science Foundation of China
- Joint Engineering Research Center of Biomass Energy Development and Utilization, Harbin Institute of Technology
- Heilongjiang Province
- National Engineering Research Center for Safe Sludge Disposal and Resource Recovery
Zitieren
APA
Quan, X., Chen, Y., Yin, L., Zuo, W., Tian, Y., & Zhang, J. (2024). Enhanced Selective Degradation of Pharmaceutical and Personal Care Products by β-Cyclodextrin-Decorated ZIF-67 Nanocomposites in Reclaimed Water. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c05315
Vancouver
Quan X, Chen Y, Yin L, Zuo W, Tian Y, Zhang J. Enhanced Selective Degradation of Pharmaceutical and Personal Care Products by β-Cyclodextrin-Decorated ZIF-67 Nanocomposites in Reclaimed Water. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c05315
BibTeX
@article{Quan2024,
author = {Quan, Xi and Chen, Yifan and Yin, Linlin and Zuo, Wei and Tian, Yu and Zhang, Jun},
title = {Enhanced Selective Degradation of Pharmaceutical and Personal Care Products by β-Cyclodextrin-Decorated ZIF-67 Nanocomposites in Reclaimed Water},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
doi = {10.1021/acsami.4c05315}
}
EUVIMED